Trump drug pricing claim contradicted by state uncertainty

President Trump overstated state participation in a Medicaid drug pricing initiative, claiming all states were on board. Several states have not confirmed interest, indicating the administration's policy rollout may face friction. The discrepancy highlights potential implementation challenges and political spin.